Local view for "http://purl.org/linkedpolitics/eu/plenary/2013-02-06-Speech-3-206-312"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20130206.25.3-206-312"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spoken text |
"I voted in favour of this report as it will allow us to move towards ensuring that every European citizen has access to affordable medical treatment. The conditions present in the pharmaceutical market of today are vastly different to those which existed when Directive 89/105/EEC was enacted. With many medical advances having occurred and greater accessibility to generic medicines, citizens can now have much cheaper access to medical treatments. However, the time limits laid down by Directive 89/105/EEC are not working for our Member States and they are instead creating delays in the entry of new generic medicines to the market. Replacing this Directive will further facilitate the entry of such generic medicinal products to the single market and this can only benefit consumers and all European citizens by enabling them to have access to treatments which are more affordable, while also creating greater transparency in the measures regulating the prices of medicinal products."@en1
|
lpv:spokenAs | |
lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples